HiFiBiO Therapeutics is a clinical-stage global biotech pioneering a unique high-resolution translational solution (DIS®, Drug Intelligence Science) to enhance the probability of success for immunotherapies. DIS® combines unique single-cell capabilities with AI/ML approaches using patient samples to discover novel targets, effective antibody drugs, and predictive biomarkers. With DIS®, HiFiBiO gains an unprecedented understanding of immune modulation in human diseases driving a robust clinical pipeline of transformative immunotherapies. Additionally, HiFiBiO has partnered with major multinational pharmaceutical and biotech companies applying its innovative DIS® approach.
HiFiBiO Therapeutics is headquartered in Cambridge, MA with additional operations in Paris, France, Hong Kong, Shanghai, and Hangzhou, China.
Company Details
- Employees
- 56
- Founded
- 2013
- Address
- 237 Putnam Ave, Cambridge,massachusetts 02139,united States
- Industry
- Biotechnology
- Website
- https://www.hifibio.com
- Keywords
- Microfluidics, Single-cell, Antibodies, Therapeutics, drug discovery, Target discovery, biomarker discovery, artificial intelligence, machine learning, immune modulation.
- HQ
- Cambridge, Massachusetts
Hifibio Therapeutics Questions
Hifibio Therapeutics's website is https://www.hifibio.com
Hifibio Therapeutics's LinkedIn profile is https://www.linkedin.com/company/hifibiotherapeutics
Hifibio Therapeutics has
56 employees.
View email and phone details for 56
employees at Hifibio Therapeutics.
Hifibio Therapeutics's industry is
Biotechnology
Hifibio Therapeutics's top competitors are
Parabilis Medicines,
Egle Therapeutics,
Acrivon Therapeutics, Inc.,
Strand Therapeutics,
Harbour Biomed,
Nimbus Therapeutics,
Saber Bio,
Acer Therapeutics Inc.,
Ksq Therapeutics, Inc.,
Novartis.
Hifibio Therapeutics's categories are Biotechnology
Hifibio Therapeutics's founding year is 2013
